She left school in 1972 with few qualifications, but that didn’t stop her going on to become one of the world’s most decorated scientists.
Not only is Dame Carol the first woman to hold a full professorship in Chemistry at both Oxford and Cambridge universities, she’s also the founder of OMass Therapeutics, a trailblazing OSE portfolio company in the biotech sector.
The company builds on Dame Carol’s pioneering work in ‘native mass spectrometry’ – a technique for studying proteins in their natural state. The technique has revolutionised structural biology and paved the way for breakthroughs in small drug discovery.
